🏛️
Source-reviewed study unitAbout 11 minutes

Use agency-specific data and resolve status messages

Ability objective

Build a commodity-specific PGA data set, distinguish technical rejects from agency review, and resolve holds or requests through the correct channel.

Answer first

Core rule

Answer first: PGA data are agency- and commodity-specific. Use the applicable supplemental guide to determine commercial description, product code, intended use, entities, licenses or affirmations, and supporting documents; broad tariff descriptions and fields copied from another agency are not substitutes. Distinguish an ACE transmission acceptance or reject from the PGA's admissibility review, hold, document request, or refusal. A refusal by the responsible PGA prevents entry into U.S. commerce, but timing and release dependencies vary by agency and must not be generalized. October 2026 exam answers remain tied to designated references; current CBP/FDA data guides are a separately versioned operations layer. CBLE Ace currently has no dedicated verified PGA question pool for this topic; route practice to the general practice page and keep verification status pool-insufficient.

Authority and lookup route

Locate the rule before returning to the facts. Links point to government or official publications.

CBP ACE Cargo Release Business Rules for Trade, Version 4.0

PGA requirements → agency supplemental guides → PGA status and release processing

Current operational guidance reviewed August 18, 2026. Host: U.S. Customs and Border Protection (cbp.gov). It is not automatically an October 2026 exam authority unless CBP designates or incorporates it.

Read on CBLE Ace →
Government original ↗
FDA, Transmitting Required Information

FDA-regulated product → mandatory and optional data → supplemental guide → document response

Current operational guidance reviewed August 18, 2026. Host: U.S. Food and Drug Administration (fda.gov). It is not automatically an October 2026 exam authority unless CBP designates or incorporates it.

FDA ACE/ITDS

FDA ACE resources → error messages, status notifications, and agency support

Current operational guidance reviewed August 18, 2026. Host: U.S. Food and Drug Administration (fda.gov). It is not automatically an October 2026 exam authority unless CBP designates or incorporates it.

CBP October 28, 2026 CBLE Reference Materials Notice

Preparing for the CBLE → Reference Materials → designated HTS, CFR, and CBP policy documents

Official CBP exam notice verified August 18, 2026.

Reference lookup task

Choose one regulated commodity and list the correct agency guide, exact commercial description, product and intended-use codes, required entities, mandatory affirmations, document channel, and status owner.

Route: Start at the CBP PGA implementation-guide index, open the agency's own guide, then use the agency's status or document system rather than another PGA's workflow.

Worked example

A filer enters an FDA-regulated human drug as 'pharmaceutical product' and copies APHIS PGA codes. ACE returns a technical or agency error before FDA admissibility is complete.

  1. 1Replace the broad description with complete commercial terminology supported by the invoice and product facts.
  2. 2Use the FDA—not APHIS—supplemental guide to determine product code, intended use, entities, and mandatory affirmations.
  3. 3Identify whether the response is a CBP transmission reject or an FDA status or document request.
  4. 4Correct through the matching channel and wait for the responsible agency's disposition rather than treating retransmission acceptance as release.

Conclusion: Rebuild the line from the FDA-specific guide and resolve the actual message owner; neither copied APHIS data nor ACE retransmission acceptance establishes FDA admissibility.

Common traps

  • Using a tariff description or vague product family instead of complete commercial terminology.
  • Treating one agency's codes, affirmations, or status meanings as universal PGA fields.
  • Equating successful ACE transmission with the responsible agency's release decision.
  • Assuming every PGA blocks release at the same processing point.
  • Creating verified progress from an unsupported general-practice visit.